PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) — SEC Financial Statements & Analysis

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) is a laboratory analytical instruments company, incorporated in DE. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. trades on Nasdaq as: PACB. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. carries a market cap of $521.90M, a P/E ratio of -3.97x, a P/B ratio of -15.71x, a P/S ratio of 4.55x, an enterprise value of $1.11B, and an EV/EBITDA multiple of -8.96x. On profitability, it posts a gross margin of 50.55%, an operating margin of -116.07%, a net margin of -114.62%, a Return on Equity (ROE) of -929.32%, a Return on Assets (ROA) of -16.66%, and a Return on Invested Capital (ROIC) of -22.06%. Per share, it reports EPS of $-0.42, diluted EPS of $-0.42, free cash flow per share of $-0.40, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -1.93% year-over-year, net income growth of -75.04% year-over-year, and EPS growth of -75.88% year-over-year. On the balance sheet, it maintains a current ratio of 4.92x, a quick ratio of 3.90x, working capital of $269.83M, a debt-to-equity ratio of -23.64x, a debt ratio of 1.04, an interest coverage ratio of -18.15x, free cash flow of $-123.59M (TTM), and net debt of $583.33M. Figures sourced from SEC EDGAR.

Market Cap

$521.90M

P/E TTM

-3.97x

EPS TTM

$-0.42

P/B TTM

-15.71x

ROE TTM

-929.32%

ROA TTM

-16.66%

Debt To Equity

-23.64x

Free Cash Flow TTM

$-123.59M

Net Revenue TTM Growth 1Y

-1.93%

Data as of 2026-06-30 · Source: SEC EDGAR